Synthesis and bioactivity evaluation of 3-hydroxy-3-(phenylethynyl)indol-2- one analogues

Journal of Heterocyclic Chemistry

Volumn 46, Issue 2, 2009, Pages 217-220

  Chen, Gang ^a,b   Wang, Ye ^c   Gao, Suo ^a   He, Hong Ping ^a   Li, Shun N ^a   Zhang, Jian Xin ^c   Ding, Jian ^d   Hao, Xiao Jiang ^a,c  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b XI'AN SHIYOU UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALLYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 1 BENZYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 1 BUTYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 1 ETHYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 1 HEXYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 1 METHYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 1 PROPYL 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; 3 HYDROXY 3 (PHENYLETHYNYL)INDOL 2 ONE; 3 HYDROXY 3 (PHENYLETHYNYL)INDOLIN 2 ONE; ACETIC ACID DERIVATIVE; ALCOHOL; ALPHA TOCOPHEROL; CARBONYL DERIVATIVE; ETHYL 2 (3 HYDROXY 2 OXO 3 (PHENYLETHYNYL)INDOLIN 1 YL)ACETATE; HYDROGEN PEROXIDE; INDOLE DERIVATIVE; ISATIN; ISATIN DERIVATIVE; LIGAND; PHENYLACETYLENE; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CHEMICAL ANALYSIS; CHEMICAL REACTION; CONTROLLED STUDY; CYCLOADDITION; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; LUNG CANCER; NEUROPROTECTION; NONHUMAN; SUBSTITUTION REACTION;

EID: 65349125843     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.58     Document Type: Article

References (20)

1. Marshall, J. A. Bourbeau, M. P. Org Lett 2003, 5, 3197.
2. Siemsen, P. Livingston, R. C. Diederich, F. Angew Chem Int Ed 2000, 39, 2632.
3. Teruhiko, I. Tomohiro, M. Kumiko, H. Toshiaki, A. Takayuki, K. Seiki, S. J Org Chem 2003, 68, 3702.
4. Sarah, V. M. Daesung, L. Org Lett 2005, 7, 4995.
5. Marie, G. Valerie, B. Campagne, J. M. J Am Chem Soc 2005, 127, 14180.
6. Neel, K. A. Erick, M. C. J Am Chem Soc 2001, 123, 9687.
7. Ryo, T. Kenichiro, Y. Takashi, O. Masakatsu, S. J Am Chem Soc 2005, 127, 13760.
8. Barry, M. T. Andrew, H. W. Axel, J. W. J Am Chem Soc 2006, 128, 8.
9. Wang, Z.-J. Chen, H.-Z.,Lu, Y. Chin Pharm J 2005, 40, 1073.
10. Fujioka, T. Furumi, K. Fuji, H. Chem Pharm Bull 1999, 47, 96.
11. Gil-Turnes, M. S. Hay, M. E. Fenical, W. Science 1989, 246, 116.
12. Glover, V. Halket, J. M. Watkins, P. J. Clow, A. Goodwin, B. L. Sandler, M. J Neurochem 1988, 51, 656.
13. Medvedev, A. E. Clow, A. Sandler, M. Glover, V. Biol Psychiatry 1996, 52, 385.
14. Ding, K. Lu, Y. Zaneta, N. C. Su, Q. Ding, Y. Gao, W. Jeanne, S. Krzysztof, K. Peter, P. R. York, T. D. Parrish, A. Deschamps, J. R. Wang, S. J Am Chem Soc 2005, 127, 10130.
15. Motzer, R. J. Rini, B. I. Michaelson, M. D. Redman, B. G. Hudes, G. R. Wilding, G. Figlin, R. A. Zhu, J. Kim, S.-T. Baum, C. J Clin Oncol 2004, 22, 4500.
16. Abdel-Rahman, A. H. Keshk, E. M. Hanna, M. A. El- Bady, S. M. Bioorg Med Chem 2004, 12, 2483.
17. Ried, W. Suarez-Rivero, E. Chem Ber 1963, 96, 1475.
18. Pier, G. C. Jens, R. Carsten, B. Norrby, P. O. Claudia, T. J Org Chem 2005, 70, 5733.
19. Wei, C.-L. Yu, D.-H. An, L.-J. Chin J Mod Med 2004, 14, 73.
20. Mosmann, T. J Immunol Methods 1983, 65, 55.